351 results on '"Boterberg, T."'
Search Results
2. Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience
3. The Evidence for External Beam Radiotherapy in High-Risk Neuroblastoma of Childhood: A Systematic Review
4. Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study
5. PO-1737 Profile of centres participating in paediatric radiotherapy clinical trials: initial QUARTET report
6. OC-0422 Treatment planning compliance rates in paediatric clinical trials: preliminary report from QUARTET
7. Radiotherapy quality assurance outcome and its correlation with survival in the SIOPEN High-Risk Neuroblastoma trial (HR-NBL1/SIOPEN). A report from the radiotherapy committee
8. P11.28.A Cancer registration and adherence to the WHO 2016 classification of pathology reports for astrocytic tumors in Belgium from 2017 to 2019
9. Omega-3 fatty acids: physiology, biological sources and potential applications in supportive cancer care
10. Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I–II study
11. Integration of geriatric oncology in daily multidisciplinary cancer care: the time is now
12. Quality indicators in neuro-oncology: modified Delphi process for the development of a quality indicator set for assessment of glioma care
13. P14.22 Quality indicators in neuro-oncology: modified Delphi process for the development of a quality indicator set for assessment of glioma care
14. Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life
15. Inter-Clinician Delineation Variation for a New Highly-Conformal Flank Target Volume in Children with Renal Tumors: A Siop-Renal Tumor Study Group International Multicenter Exercise
16. PO-1259: Adoption of single-fraction radiotherapy for uncomplicated bone metastases in a tertiary centre
17. Subventricular zone contacting glioblastoma: tumor size, molecular biological factors and patient survival
18. In vitro cytotoxicity of paclitaxel/β-cyclodextrin complexes for HIPEC
19. Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives
20. Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study
21. Towards a Consensus on Normal Tissues of Interest for the Paediatric Radiotherapy Population
22. P14.116 Lack of correlation between incidental ipsilateral subventricular zone radiation dose and overall survival in glioblastoma patients
23. P14.109 Standard error of measurement (SEM) and intraclass coefficient (ICC) in volumetric assessment of postoperative residual tumor volume in glioblastoma
24. SP-0137 Radiotherapy in children and adolescents. What do we know until now and what will the future bring?
25. SP-0110 Magnetic resonance based small animal radiotherapy in neuro-oncology
26. OC-0380 Dose response relation in esophageal cancer after neoadjuvant therapy: multi-institutional analysis
27. Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group
28. P04.82 [18F]-FET and [18F]-FAZA PET based radiotherapy of F98 glioblastoma rats
29. P01.007 Absence of Correlation between Necrosis Volume and Overall Survival in Glioblastoma
30. P08.03 In-vivo DCE-MRI for the discrimination between glioblastoma and radiation necrosis in rats
31. Integration of geriatric oncology in daily multidisciplinary cancer care: the time is now
32. Adjuvante behandeling bij coloncarcinoom: is het 5-fluorouraciltijdperk voorbij?
33. Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis
34. Successful strategy to treat a solitary cystic melanoma brain metastasis
35. P07.22 Kinetic modeling and graphical analysis of 18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET) and 18F-fluorodeoxyglucose (FDG) PET for the discrimination between high-grade glioma and radiation necrosis in rats
36. EP-1535: Electron Skin Irradiation: refinement of an abutting field technique
37. Final report on Quality Insurance of rectal cancer - phase 3: statistical methods to benchmark centers on a set of quality indicators
38. Differentiation between peri-anastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data
39. PD-0420: Randomised escalation trial with adaptive dose painting by numbers for head and neck cancer: interim analysis
40. EP-1149 Feasibility trial of 3-phase adaptive dose painting by numbers for head and neck cancer: 3 years clinical results
41. PO-087: Long-term outcome of 18F-FDG-PET-guided dose painting for head-and-neck cancer: matched case-controlled study
42. Safety analysis of randomized Belgian phase II trial of extended use of adjuvant temozolomide in newly diagnosed glioblastoma patients
43. Effect of Neoadjuvant Radiation Dose on Surgical and Oncological Outcome in Locally Advanced Esophageal Cancer
44. PP075-MON: Echium Oil is not Protective Against Weight Loss in Head and Neck Cancer Patients Undergoing Curative Radiotherapy
45. P16.04 * USE OF 18F-FLUOROMETHYLCHOLINE PET IN EARLY TREATMENT RESPONSE ASSESSMENT IN GLIOBLASTOMA PATIENTS
46. Hypofractionation vs Conventional Radiation Therapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Matched-Cohort Analysis
47. Late-onset post-irradiation vasculopathy of the posterior cerebral vasculature.
48. Safety analysis of randomized Belgian phase II trial of extended use of adjuvant temozolomide in newly diagnosed glioblastoma patients
49. Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma : a prospective dose finding phase I-II study
50. PO-0657: Late dysphagia, xerostomia, neck fibrosis and toxic death after IMRT for head and neck cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.